Does the rubella immunoglobulin G affect the severity of COVID-19? Rubella immunoglobulin G and COVID-19

Letter Allergy

Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course

Desiree E. Larenas-Linnemann et al.

ALLERGY (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness COMMENT

J. Wesson Ashford et al.

AMERICAN JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Environmental Sciences

Measles and Rubella during COVID-19 Pandemic: Future Challenges in Japan

Kazuki Shimizu et al.

Summary: The COVID-19 pandemic has impacted essential health services, but also raised awareness of personal hygiene and preventive measures. Despite eliminating measles in 2015, Japan has seen an increase in measles and rubella patients in recent years. While the transmission of these diseases seems to be suppressed during the pandemic, the challenge lies in closing the gap in routine childhood vaccination.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

添加到收藏夹

Letter Microbiology

Reply to Marakasova and Baranova, MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection

Jeffrey E. Gold et al.

Summary: The researchers suggest that the decline in mumps IgG titers over time could serve as a proxy measure of overall MMR II vaccine persistence, and they acknowledge that the observed results may be related to any component of the MMR II vaccine. They present a conventional approach of matching protein sequence and structure to antibodies generated during and after vaccination or disease.

MBIO (2021)

添加到收藏夹

Letter Microbiology

MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection

Ekaterina Marakasova et al.

MBIO (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations

Colin Pawlowski et al.

Summary: Clinical studies are being conducted to evaluate the potential of existing vaccines in providing protection against SARS-CoV-2 through trained immunity. Analysis of immunization records from 137,037 individuals who underwent SARS-CoV-2 PCR tests revealed associations between various vaccines and decreased infection rates, with a significant reduction among black individuals who received the PCV13 vaccine.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Immunology

Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study

Lisa Lundberg et al.

Summary: The study suggests a potential protective effect of the MMR vaccine against SARSCoV-2, especially in males, based on a test negative case-control study during a recent measles outbreak.

VACCINE (2021)

添加到收藏夹

Letter Medicine, General & Internal